期刊文献+

预测新诊断癫痫患者单药治疗效果的多因素Cox回归分析 被引量:1

下载PDF
导出
摘要 目的分析新诊断癫痫患者药物治疗效果不佳的因素。方法收集125例新诊断癫痫患者的临床资料,以开始治疗后初衣发作时间和治疗失败时间为观察指标,采用多因素Cox归,分析癫痫患者临床资料对药物治疗效果的影响。结果多因素Cox回归分析显示:癫痫家族史、治疗后脑电图(EEG)癫痫波样异常、治疗前发作次数多是影响治疗后初次发作时间的因素。而治疗后EEG癫痫波样异常、继发性癫痫、头颅影像学异常、部分性发作是影响治疗失败时间的因素。结论具有EEG癫痫泼样异常、癫痫家族史、治疗前发作次数多、部分性发作、继发性癫痫、头颅影像学异常是新诊癫痫患者早期药物治疗效果差的危险因素。
出处 《浙江临床医学》 2016年第2期320-321,共2页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献5

  • 1Baulac M,Patten A,Giorgi L. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: Results of a phase III,randomized,double-blind study, epilepsia,2014,55(10): 1534-1543.
  • 2ILAE Subconarmssion on AED Guidelines.Updated ILAE evidence review of antiepileptic drug eflficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes,Epilepsia,2013,54(3): 551-563.
  • 3SANAD Study Group.The SANAD study of effectiveness of carb amazepine,gabap entin,lamotrigine,oxcarbazepine,or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet,2007,369(12): 1000--1015.
  • 4Kwan P,Brodie MJ.Early identification of refractory epilepsy. N Engl J Med,2000,342(11): 314-319.
  • 5吴光声,高峰,沈征,毛姗姗,沈珏,袁哲峰,李珊.10个全面性癫痫伴热性惊厥附加症家系的SCN1A基因突变筛查研究[J].解放军医学杂志,2014,39(10):804-807. 被引量:9

二级参考文献20

  • 1魏建科,魏华,黄希顺,尹景岗,卢宏,黄素娟,顾仁骏,贾福军,李冲,霍卫红,Lemuel Racacho,王家勤,郭学鹏,Dennis Bulman.全身性癫癎伴热性惊厥附加症2个家系致病基因GABRG2测序分析[J].郑州大学学报(医学版),2006,41(6):1049-1052. 被引量:4
  • 2Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogen-eous clinical phenotypes[J]. Brain, 1997, 120(Vt3): 479-490.
  • 3Engel J Jr, International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology[J]. Epilepsia, 2001, 42(6): 796-803.
  • 4Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005- 2009 [J]. Epilepsia, 2010, S 1(4): 676-685.
  • 5Scheffer IE, Zhang YH, Gecz J, et al. Genetics of the epilepsies: genetic twists in the channels and other tales[J]. Epilepsia, 2010, 51(Suppl 1): 33-36.
  • 6Hirkin LA, McMahon JM, Iona X, et al. The spectrum of SCN1A-related infantile epileptic encephalopathies[J]. Brain, 2007, 130(Pt3): 843-852.
  • 7Wallace RH, Hodgson BL, Grinton BE, et al. Sodium channel alphal-subunit mutation in severe myoclonic epilepsy of infancy and infantile spasms[J]. Neurology, 2003, 61 (6): 765-769.
  • 8MariniC, Scheffer IE, Nabbout R, et al. The genetics of Dravet syndrome[J]. Epilepsia, 201 1, 52(Suppl 2): 24-29.
  • 9Ceulemans BP, Claes LR, Lagae LG. Clinical correlations of mutations in the SCNIA gene.- from febrile seizures to severe myodonic epilepsy in infancy[J]. Pediatr Neurol, 2004, 30(4): 236-243.
  • 10Lossin C. A catalog of SCNIA variants[J]. Brain Dev, 2009, 31(2): 114-130.

共引文献8

同被引文献25

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部